Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase-Reference-Cited by-同舟云学术

Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase

Published:2011-06-16 Issue:S1 Volume:33 Page:E73-E101
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Lucas Susana D.¹,Costa Elsa¹,Guedes Rita C.¹,Moreira Rui¹

Affiliation:

1. Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL); Faculty of Pharmacy, University of Lisbon. Av. Prof. Gama Pinto; 1649-003; Lisbon; Portugal

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference119 articles.

1. On the size of the active site in proteases. I. Papain;Schechter;Biochem Biophys Res Commun,1967

2. http://www.who.int/respiratory/copd/en/ 2011

3. Attacking the multi-tiered proteolytic pathology of COPD: New insights from basic and translational studies;Djekic;Pharmacol Ther,2009

4. COPD: Current therapeutic interventions and future approaches;Barnes;Eur Respir J,2005

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sivelestat (Neutrophil Elastase Inhibitor) as Anti-inflammatory and Anti-viral Agent: An In Silico Study;Cureus;2024-03-24

2. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology;Chemical Reviews;2024-02-21

3. Desmosine as a biomarker for the emergent properties of pulmonary emphysema;Frontiers in Medicine;2023-12-18

4. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome;Expert Opinion on Investigational Drugs;2023-09-02

5. Human neutrophil elastase inhibitors: Classification, biological‐synthetic sources and their relevance in related diseases;Fundamental & Clinical Pharmacology;2023-08-23